Improving Carboplatin Dosing Based on Estimated GFR.
作者信息
Beumer Jan H, Inker Lesley A, Levey Andrew S
机构信息
Cancer Therapeutics Program, UPMC Hillman Cancer Center, Pittsburgh, PA; Department of Pharmaceutical Sciences, University of Pittsburgh School of Pharmacy, Pittsburgh, PA; Division of Hematology/Oncology, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA.
Division of Nephrology, Tufts Medical Center, Boston, MA.
出版信息
Am J Kidney Dis. 2018 Feb;71(2):163-165. doi: 10.1053/j.ajkd.2017.10.005. Epub 2017 Dec 6.
Abstract
摘要
相似文献
1
Improving Carboplatin Dosing Based on Estimated GFR.基于估算肾小球滤过率改进卡铂给药剂量
Am J Kidney Dis. 2018 Feb;71(2):163-165. doi: 10.1053/j.ajkd.2017.10.005. Epub 2017 Dec 6.
2
Performance of formulae based estimates of glomerular filtration rate for carboplatin dosing in stage 1 seminoma.公式估算肾小球滤过率在 1 期精原细胞瘤卡铂给药中的表现。
Eur J Cancer. 2014 Mar;50(5):944-52. doi: 10.1016/j.ejca.2013.12.021. Epub 2014 Jan 17.
3
Evaluation of predictive formulae for glomerular filtration rate for carboplatin dosing in gynecological malignancies.用于妇科恶性肿瘤中卡铂给药的肾小球滤过率预测公式的评估
Gynecol Oncol. 2006 Dec;103(3):1063-9. doi: 10.1016/j.ygyno.2006.06.024. Epub 2006 Jul 27.
4
Glomerular filtration rate estimation for carboplatin dosing in patients with gynaecological cancers.估算妇科癌症患者卡铂给药剂量的肾小球滤过率。
ESMO Open. 2022 Apr;7(2):100401. doi: 10.1016/j.esmoop.2022.100401. Epub 2022 Feb 26.
5
Fundamental problems with pediatric adaptive dosing of carboplatin using nuclear-medicine-based estimates of renal function.基于核医学的肾功能估计对小儿卡铂适应性剂量的基本问题。
Pediatr Blood Cancer. 2019 Jun;66(6):e27672. doi: 10.1002/pbc.27672. Epub 2019 Feb 15.
6
Carboplatin dosing based on measurement of renal function--experience at the Peter MacCallum Cancer Institute.基于肾功能测量的卡铂给药——彼得·麦卡勒姆癌症研究所的经验
Aust N Z J Med. 1996 Jun;26(3):372-9. doi: 10.1111/j.1445-5994.1996.tb01925.x.
7
Accurate determination of glomerular filtration rate in adults for carboplatin dosing: Moving beyond Cockcroft and Gault.成人卡铂给药剂量时肾小球滤过率的准确测定：超越 Cockcroft 和 Gault。
J Oncol Pharm Pract. 2021 Mar;27(2):368-375. doi: 10.1177/1078155220978446. Epub 2020 Dec 9.
8
Measured versus estimated glomerular filtration rate in the Calvert equation: influence on carboplatin dosing.卡尔弗特方程中测量的与估算的肾小球滤过率：对卡铂给药剂量的影响。
Cancer Chemother Pharmacol. 2001 May;47(5):373-9. doi: 10.1007/s002800000260.
9
Carboplatin dosing in the era of IDMS-creatinine; the Cockroft-Gault formula no longer provides a sufficiently accurate estimate of glomerular filtration rate for routine use in clinical care.在采用 IDMS-肌酐法进行卡铂剂量调整的时代， Cockroft-Gault 公式不再能为临床常规提供足够准确的肾小球滤过率估计值。
Gynecol Oncol. 2020 Jun;157(3):793-798. doi: 10.1016/j.ygyno.2020.03.017. Epub 2020 Mar 24.
10
Investigating current practices in renal function measurement and carboplatin dosing in children with cancer - a UK perspective.从英国视角探讨癌症患儿肾功能测量及卡铂给药的当前实践
Pediatr Hematol Oncol. 2020 Apr;37(3):235-244. doi: 10.1080/08880018.2020.1713939. Epub 2020 Jan 16.
引用本文的文献
1
Aligning kidney function assessment in patients with cancer to global practices in internal medicine.使癌症患者的肾功能评估与全球内科实践保持一致。
EClinicalMedicine. 2025 Mar 25;82:103102. doi: 10.1016/j.eclinm.2025.103102. eCollection 2025 Apr.
2
Integrating International Consensus Guidelines for Anticancer Drug Dosing in Kidney Dysfunction (ADDIKD) into everyday practice.将《国际肾功能不全患者抗癌药物剂量共识指南》（ADDIKD）融入日常实践。
EClinicalMedicine. 2025 Mar 25;82:103161. doi: 10.1016/j.eclinm.2025.103161. eCollection 2025 Apr.
3
From Prospective Evaluation to Practice: Model-Informed Dose Optimization in Oncology.从前瞻性评估到实践：肿瘤学中基于模型的剂量优化
Drugs. 2025 Apr;85(4):487-503. doi: 10.1007/s40265-025-02152-6. Epub 2025 Feb 12.
4
Carboplatin dose calculations for patients with lung cancer: significant dose differences found depending on dosing equation choice.肺癌患者的卡铂剂量计算：根据给药方程选择的不同，剂量差异显著。
BMC Cancer. 2022 Jul 30;22(1):829. doi: 10.1186/s12885-022-09885-7.
5
Improving the tolerability of osimertinib by identifying its toxic limit.通过确定奥希替尼的毒性极限来提高其耐受性。
Ther Adv Med Oncol. 2022 Jun 3;14:17588359221103212. doi: 10.1177/17588359221103212. eCollection 2022.
6
Comparison of Equations To Estimate Glomerular Filtration Rate and Their Impact on Frequency of Cisplatin-associated Acute Kidney Injury.比较估算肾小球滤过率的方程及其对顺铂相关性急性肾损伤频率的影响。
Kidney360. 2020 Dec 29;2(2):205-214. doi: 10.34067/KID.0000572020. eCollection 2021 Feb 25.
7
Carboplatin Dosing in Children Using Estimated Glomerular Filtration Rate: Equation Matters.使用估计肾小球滤过率计算儿童卡铂剂量：公式很重要。
Cancers (Basel). 2021 Nov 26;13(23):5963. doi: 10.3390/cancers13235963.
8
Use of Gemcitabine plus Carboplatin is Associated with Poor Outcomes in Urothelial Carcinoma Patients with Chronic Kidney Disease Stage 4-5.吉西他滨联合卡铂的使用与慢性肾脏病 4-5 期尿路上皮癌患者的不良预后相关。
Cancer Res Treat. 2021 Oct;53(4):1166-1173. doi: 10.4143/crt.2021.091. Epub 2021 Mar 4.
9
Performance of Glomerular Filtration Rate Estimating Equations Before and After Bariatric Surgery.减肥手术前后肾小球滤过率估算方程的性能
Kidney Med. 2020 Oct 17;2(6):699-706.e1. doi: 10.1016/j.xkme.2020.08.008. eCollection 2020 Nov-Dec.
10
CamGFR v2: A New Model for Estimating the Glomerular Filtration Rate from Standardized or Non-standardized Creatinine in Patients with Cancer.CamGFR v2：一种用于估算癌症患者标准化或非标准化肌酐肾小球滤过率的新模型。
Clin Cancer Res. 2021 Mar 1;27(5):1381-1390. doi: 10.1158/1078-0432.CCR-20-3201. Epub 2020 Dec 10.
本文引用的文献
1
New Model for Estimating Glomerular Filtration Rate in Patients With Cancer.癌症患者肾小球滤过率估算的新模型
J Clin Oncol. 2017 Aug 20;35(24):2798-2805. doi: 10.1200/JCO.2017.72.7578. Epub 2017 Jul 7.
2
Assessment of Glomerular Filtration Rate in Health and Disease: A State of the Art Review.健康与疾病状态下肾小球滤过率的评估：最新综述
Clin Pharmacol Ther. 2017 Sep;102(3):405-419. doi: 10.1002/cpt.729. Epub 2017 Jun 5.
3
Cystatin C-Guided Vancomycin Dosing in Critically Ill Patients: A Quality Improvement Project.胱抑素 C 指导下的危重症患者万古霉素剂量调整：一项质量改进项目。
Am J Kidney Dis. 2017 May;69(5):658-666. doi: 10.1053/j.ajkd.2016.11.016. Epub 2017 Jan 25.
4
Iohexol plasma clearance for measuring glomerular filtration rate in clinical practice and research: a review. Part 1: How to measure glomerular filtration rate with iohexol?临床实践和研究中用于测量肾小球滤过率的碘海醇血浆清除率：综述。第1部分：如何用碘海醇测量肾小球滤过率？
Clin Kidney J. 2016 Oct;9(5):682-99. doi: 10.1093/ckj/sfw070. Epub 2016 Aug 23.
5
Cisplatin versus carboplatin: comparative review of therapeutic management in solid malignancies.顺铂与卡铂：实体恶性肿瘤治疗管理的比较综述。
Crit Rev Oncol Hematol. 2016 Jun;102:37-46. doi: 10.1016/j.critrevonc.2016.03.014. Epub 2016 Mar 24.
6
GFR as the "Gold Standard": Estimated, Measured, and True.作为“金标准”的肾小球滤过率：估算值、测量值与真实值
Am J Kidney Dis. 2016 Jan;67(1):9-12. doi: 10.1053/j.ajkd.2015.09.014.
7
Relevant risk of carboplatin underdosing in cancer patients with normal renal function using estimated GFR: lessons from a stage I seminoma cohort.基于估算肾小球滤过率的肾功能正常癌症患者中卡铂剂量不足的相关风险：来自 I 期精原细胞瘤队列的经验教训。
Ann Oncol. 2014 Aug;25(8):1591-7. doi: 10.1093/annonc/mdu129. Epub 2014 Mar 25.
8
GFR estimation: from physiology to public health.肾小球滤过率估计：从生理学到公共卫生。
Am J Kidney Dis. 2014 May;63(5):820-34. doi: 10.1053/j.ajkd.2013.12.006. Epub 2014 Jan 28.
9
Comments on 'KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease'.对《KDIGO 2012慢性肾脏病评估与管理临床实践指南》的评论
Kidney Int. 2013 Sep;84(3):622-3. doi: 10.1038/ki.2013.243.
10
Dosing of cytotoxic chemotherapy: impact of renal function estimates on dose.细胞毒化疗药物剂量：肾功能评估对剂量的影响。
Ann Oncol. 2013 Nov;24(11):2746-52. doi: 10.1093/annonc/mdt300. Epub 2013 Aug 7.
Zotero 插件